Clinical Trial Update: Study of AZD0466 Monotherapy or in Combination in Patients With Advanced Haematological Malignancies [Phase 1]

View source ↗

Summary

A Phase 1 trial of AZD0466 as monotherapy or in combination in patients with advanced hematologic malignancies has been terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies

Drugs mentioned

• AZD0466

Snippet

Sponsor: AstraZeneca | Conditions: Haematological Malignancies | Phase 1 | Status: TERMINATED | Results posted: 2025-06-15